Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 20.4 HKD 12.46% Market Closed
Market Cap: 6.6B HKD

Intrinsic Value

The intrinsic value of one Zylox-Tonbridge Medical Technology Co Ltd stock under the Base Case scenario is 16.96 HKD. Compared to the current market price of 20.4 HKD, Zylox-Tonbridge Medical Technology Co Ltd is Overvalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
16.96 HKD
Overvaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zylox-Tonbridge Medical Technology Co Ltd

Zylox-Tonbridge Medical Technology Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Zylox-Tonbridge Medical Technology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Zylox-Tonbridge Medical Technology Co Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Zylox-Tonbridge Medical Technology Co Ltd’s research
View All Researches
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
CN
Health Care
Market Cap
6.6B HKD
IPO
Jul 5, 2021
CN
Health Care
Market Cap
6.6B HKD
IPO
Jul 5, 2021
Price
HK$false
EPS
ÂĄfalse
AI Assistant
AI Assistant
Ask me anything about Zylox-Tonbridge Medical Technology Co Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Zylox-Tonbridge Medical Technology Co Ltd

Balance Sheet Decomposition
Zylox-Tonbridge Medical Technology Co Ltd

Current Assets 1.4B
Cash & Short-Term Investments 1.2B
Receivables 16.2m
Other Current Assets 193.6m
Non-Current Assets 2.1B
Long-Term Investments 1.4B
PP&E 655m
Intangibles 34.7m
Other Non-Current Assets 3m
Efficiency

Free Cash Flow Analysis
Zylox-Tonbridge Medical Technology Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zylox-Tonbridge Medical Technology Co Ltd

Revenue
782.5m CNY
Cost of Revenue
-222.6m CNY
Gross Profit
559.9m CNY
Operating Expenses
-523.7m CNY
Operating Income
36.2m CNY
Other Expenses
64m CNY
Net Income
100.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Zylox-Tonbridge Medical Technology Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
44/100
Profitability
Score

Zylox-Tonbridge Medical Technology Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Zylox-Tonbridge Medical Technology Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Long-Term Solvency
Negative Net Debt
95/100
Solvency
Score

Zylox-Tonbridge Medical Technology Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Zylox-Tonbridge Medical Technology Co Ltd

Wall Street analysts forecast Zylox-Tonbridge Medical Technology Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zylox-Tonbridge Medical Technology Co Ltd is 19.18 HKD with a low forecast of 18.79 HKD and a high forecast of 19.95 HKD.

Lowest
Price Target
18.79 HKD
8% Downside
Average
Price Target
19.18 HKD
6% Downside
Highest
Price Target
19.95 HKD
2% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Zylox-Tonbridge Medical Technology Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Zylox-Tonbridge Medical Technology Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Zylox-Tonbridge Medical Technology Co Ltd stock?

The intrinsic value of one Zylox-Tonbridge Medical Technology Co Ltd stock under the Base Case scenario is 16.96 HKD.

Is Zylox-Tonbridge Medical Technology Co Ltd stock undervalued or overvalued?

Compared to the current market price of 20.4 HKD, Zylox-Tonbridge Medical Technology Co Ltd is Overvalued by 17%.

Back to Top